Citigroup’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-107,635
Closed -$649K 5362
2019
Q4
$649K Sell
107,635
-319,801
-75% -$1.93M ﹤0.01% 2476
2019
Q3
$1.54M Buy
427,436
+106,040
+33% +$382K ﹤0.01% 1798
2019
Q2
$861K Buy
321,396
+293,712
+1,061% +$787K ﹤0.01% 2260
2019
Q1
$82K Sell
27,684
-340,046
-92% -$1.01M ﹤0.01% 3716
2018
Q4
$584K Buy
367,730
+148,666
+68% +$236K ﹤0.01% 2394
2018
Q3
$806K Buy
219,064
+30,757
+16% +$113K ﹤0.01% 2160
2018
Q2
$533K Buy
188,307
+23,897
+15% +$67.6K ﹤0.01% 2300
2018
Q1
$610K Sell
164,410
-70,930
-30% -$263K ﹤0.01% 2171
2017
Q4
$678K Buy
235,340
+141,118
+150% +$407K ﹤0.01% 2151
2017
Q3
$423K Sell
94,222
-8,209
-8% -$36.9K ﹤0.01% 2531
2017
Q2
$471K Buy
102,431
+21,077
+26% +$96.9K ﹤0.01% 2460
2017
Q1
$342K Sell
81,354
-461,259
-85% -$1.94M ﹤0.01% 2641
2016
Q4
$2.24M Buy
542,613
+500,568
+1,191% +$2.07M ﹤0.01% 1735
2016
Q3
$340K Buy
42,045
+14,492
+53% +$117K ﹤0.01% 2686
2016
Q2
$215K Sell
27,553
-89,278
-76% -$697K ﹤0.01% 2814
2016
Q1
$902K Buy
116,831
+83,432
+250% +$644K ﹤0.01% 2153
2015
Q4
$361K Sell
33,399
-47,309
-59% -$511K ﹤0.01% 2615
2015
Q3
$558K Buy
80,708
+49,429
+158% +$342K ﹤0.01% 2135
2015
Q2
$277K Sell
31,279
-13,190
-30% -$117K ﹤0.01% 2536
2015
Q1
$439K Sell
44,469
-3,967
-8% -$39.2K ﹤0.01% 2388
2014
Q4
$593K Buy
48,436
+28,903
+148% +$354K ﹤0.01% 2298
2014
Q3
$195K Sell
19,533
-11,323
-37% -$113K ﹤0.01% 2677
2014
Q2
$234K Sell
30,856
-6,280
-17% -$47.6K ﹤0.01% 2477
2014
Q1
$122K Sell
37,136
-14,988
-29% -$49.2K ﹤0.01% 3318
2013
Q4
$173K Buy
52,124
+16,718
+47% +$55.5K ﹤0.01% 3261
2013
Q3
$107K Buy
35,406
+29,153
+466% +$88.1K ﹤0.01% 3076
2013
Q2
$52K Buy
+6,253
New +$52K ﹤0.01% 3759